Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Liver transplantation

• Publication date

  2006-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.20583PMID 16382465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Living donor liver transplantation and hepatitis C

  2004cited by this paper
• FACTORS DIFFERENTIALLY CORRELATED WITH THE OUTCOME OF LIVER TRANSPLANTATION IN HCV+ AND HCV- RECIPIENTS

  2004cited by this paper
• Preservation injury patterns in liver transplantation associated with poor prognosis.

  2003influential reference
• Bile secretory function after warm hepatic ischemia‐reperfusion injury in the rat

  2003cited by this paper
• A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients

  2001cited by this paper
• Role of hepatocytes and bile duct cells in preservation‐reperfusion injury of liver grafts

  2001cited by this paper
• Postreperfusion biopsies are useful in predicting complications after liver transplantation

  2001cited by this paper
• Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients

  2000cited by this paper
• Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation

  2000cited by this paper
• Predictors of patient and graft survival following liver transplantation for hepatitis C

  1998cited by this paper
• Cholestatic hepatitis C in liver allografts.

  1998cited by this paper
• Clinical and histologic patterns of early graft failure due to recurrnet hepatitis C in four patients after liver transplantation.

  1996cited by this paper
• Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation

  1996cited by this paper

• White-light activatable organic NIR-II luminescence nanomaterials for imaging-guided surgery

  2024cites this paper
• Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production

  2021cites this paper
• Hypoxia-inducible factor-1α-dependent induction of miR122 enhances hepatic ischemia tolerance.

  2021cites this paper
• The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications—Who Is at Risk? A Collaborative Transplant Study Report

  2020cites this paper
• Implications of liver donor age on ischemia reperfusion injury and clinical outcomes.

  2020cites this paper
• New Perspectives on the Use of Sub-Optimal Donor Livers

  2019cites this paper
• Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

  2019cites this paper
• Outcomes of Controlled Donation After Cardiac Death Compared With Donation After Brain Death in Liver Transplantation: A Systematic Review and Meta-analysis.

  2018cites this paper
• Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct‐acting antivirals?

  2017cites this paper
• Donor‐derived hepatitis C transmission from NAT negative donors–Still an unexpected event!

  2017cites this paper
• Recurrent Disease Following Liver Transplantation

  2017cites this paper
• Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers

  2016cites this paper
• Hepatitis C virus and liver transplantation: where do we stand?

  2016cites this paper
• A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post‐liver transplantation?

  2015cites this paper
• Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

  2014cites this paper
• Risk factors and management of hepatitis C recurrence after liver transplantation

  2014cites this paper
• Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome

  2014cites this paper
• Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

  2014cites this paper
• Recurrent HCV after liver transplantation—mechanisms, assessment and therapy

  2014cites this paper
• Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation

  2014cites this paper
• Using old liver grafts for liver transplantation: where are the limits?

  2014cites this paper
• Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases

  2014cites this paper
• Natural History of Recurrent Hepatitis C: Impact of Immunosuppression

  2014cites this paper
• INFLUENCIA DE LOS POLIMORFISMOS GENÉTICOS DE LOS RECEPTORES "TOLL-LIKE" EN LA GRAVEDAD DE LA RECIDIVA VIRAL Y EN LA INCIDENCIA DEL RECHAZO AGUDO EN PACIENTES CON TRASPLANTE HEPÁTICO POR CIRROSIS POR EL VIRUS DE LA HEPATITIS C

  2014cites this paper
• Recurrent hepatitis C after liver transplant.

  2014cites this paper
• Strategies to reduce hepatitis C virus recurrence after liver transplantation.

  2013cites this paper
• Viral Hepatitis in Solid Organ Transplantation

  2013cites this paper
• Donor-recipient matching: myths and realities.

  2013cites this paper
• Twenty‐Year Longitudinal Follow‐Up After Orthotopic Liver Transplantation: A Single‐Center Experience of 313 Consecutive Cases

  2013cites this paper
• Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation

  2013cites this paper
• Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.

  2013cites this paper
• Management of recurrent hepatitis C in orthotopic liver transplant recipients.

  2013cites this paper
• Living-Donor Liver Transplantation and Hepatitis C

  2013cites this paper
• Natural History of Chronic HCV After Liver Transplantation

  2012cites this paper
• Prevention of hepatitis C recurrence after liver transplantation: An update.

  2012cites this paper
• Recurrent diseases following liver transplantation: current concepts

  2012cites this paper
• Chapter 50 – Recurrent Viral Diseases after Liver Transplantation

  2012cites this paper
• Liver Transplantation and Hepatitis C

  2012cites this paper
• Treating HCV After Liver Transplantation

  2012cites this paper
• Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

  2012cites this paper
• Liver transplantation using Donation after Cardiac Death donors.

  2012cites this paper
• Recurrent hepatitis C after liver transplantation.

  2012cites this paper
• Donor Graft Steatosis Influences Immunity to Hepatitis C Virus and Allograft Outcome After Liver Transplantation

  2011cites this paper
• The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients

  2011cites this paper
• Human Liver Transplantation As A Model To Study HCV Pathogenesis

  2011cites this paper
• Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence

  2011cites this paper
• Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation

  2011influential citation
• Increased Risk of Severe Recurrence of Hepatitis C Virus in Liver Transplant Recipients of Donation After Cardiac Death Allografts

  2011cites this paper
• Transplante hepático em pacientes com cirrose hepática causada pelo vírus da hepatite C

  2011cites this paper
• Recurrent Disease Following Liver Transplantation

  2011cites this paper
• A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation.

  2010cites this paper
• Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts

  2010cites this paper
• Systematic review: anti‐viral therapy of recurrent hepatitis C after liver transplantation

  2010cites this paper
• Viral Hepatitis in Solid Organ Transplant Recipients

  2009cites this paper
• A Practical Guide to the Management of HCV Infection Following Liver Transplantation

  2009cites this paper
• Human liver transplantation as a model to study hepatitis C virus pathogenesis

  2009cites this paper
• Older donors: Mounting risks for the hepatitis C–infected liver transplant recipient?

  2009cites this paper
• Long‐term outcomes of donation after cardiac death liver allografts from a single center

  2009cites this paper
• Hepatitis C recurrence after liver transplantation.

  2009cites this paper
• Molecular and Cellular Aspects of Hepatitis C Virus Reinfection After Liver Transplantation: How the Early Phase Impacts on Outcomes

  2009cites this paper
• Risk of extended criteria donors in hepatitis C virus–positive recipients

  2008cites this paper
• Donantes con criterios ampliados en trasplante hepático. Función inicial del injerto y sobrevida del receptor

  2008cites this paper
• Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury.

  2008cites this paper
• Ischemia-reperfusion injury in human liver transplantation : Mechanisms and effects on graft function

  2008cites this paper
• Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation - literature review and results of single transplantation center.

  2008cites this paper
• Ischemic preconditioning of the liver: A few perspectives from the bench to bedside translation

  2008cites this paper
• Improving the outcome of liver transplantation with very old donors with updated selection and management criteria

  2008cites this paper
• Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection

  2008cites this paper
• Risk factors for hepatitis C recurrence after liver transplantation

  2007cites this paper
• Management of hepatitis C virus in the transplant patient.

  2007cites this paper
• Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation

  2007cites this paper
• Recurrent viral liver disease (hepatitis B and C) after liver transplantation.

  2007cites this paper
• Effect of Nonviral Factors on Hepatitis C Recurrence After Liver Transplantation

  2006cites this paper
• Hepatitis C virus in liver transplantation: impact and treatment of hepatitis C virus recurrence

  2006cites this paper
• Early recurrence of hepatitis C virus infection after liver transplantation

  2006cites this paper
• [Recurrence of hepatitis C virus (HCV) infection after liver transplantation for HCV-related disease: host factors and viral factors implicated in the occurrence and the severity of HCV recurrence].

  2006cites this paper
• Current World Literature

  2006cites this paper
• Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

  2006cites this paper
• World Journal of Hepatology

  year unknowncites this paper